Glimybite Trio 2mg/500mg/0.2mg Tablet SR
Marketer
Redosine Pharmaceutical Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Glimybite Trio 2mg/500mg/0.2mg Tablet SR
Tricita 2mg/500mg/0.2mg Extended-Release Tablets are classified as antidiabetic medications. This combination therapy treats type 2 diabetes in adults by helping regulate blood glucose. Tricita should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan, including diet, exercise, and weight management as recommended by your doctor. The most frequent adverse effect is hypoglycemia (low blood sugar). Familiarize yourself with hypoglycemia symptoms—sweating, dizziness, headache, tremors—and appropriate countermeasures. Regular meals and readily available fast-acting glucose sources (e.g., sugary snacks, juice) are essential preventative steps. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur in some patients. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your doctor before commencing treatment. Pregnant or lactating women should seek medical advice before use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to track blood cell counts and liver function.
Uses of Glimybite Trio 2mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glimybite Trio 2mg/500mg/0.2mg Tablet SR:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the Glimybite Trio 2mg/500mg/0.2mg Tablet SR whole; avoid chewing, crushing, or fracturing. Consume it on an empty stomach.
Common Side effects of Glimybite Trio 2mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glimybite Trio 2mg/500mg/0.2mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Glimybite Trio 2mg/500mg/0.2mg Tablet SR whole; avoid chewing, crushing, or breaking it. Take it on an empty stomach.
How Glimybite Trio 2mg/500mg/0.2mg Tablet SR works:
The extended-release Glimybite Trio tablet (2mg/500mg/0.2mg) combines three antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimybite Trio 2mg/500mg/0.2mg SR tablets with alcohol is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using Glimybite Trio 2mg/500mg/0.2mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glimybite Trio 2mg/500mg/0.2mg tablet likely poses a risk during lactation. Available human data indicates potential transfer to breast milk, posing a possible threat to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
Employing Glimybite Trio 2mg/500mg/0.2mg Tablet SR in individuals with kidney impairment is likely inadvisable and should be forgone. Medical advice is essential. Furthermore, its use is discouraged in patients experiencing severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Glimybite Trio 2mg/500mg/0.2mg Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. Initiating treatment in individuals with mild to moderate hepatic dysfunction typically involves a low starting dose; however, it's contraindicated in those with severe liver disease.
What if you forget to take Glimybite Trio 2mg/500mg/0.2mg Tablet SR :
Should you forget a Glimybite Trio 2mg/500mg/0.2mg SR Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimybite Trio 2mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently